Maximon - The Longevity Company Builder

At the end of the year we like to reflect on this year's main achievements and successes. ✨ Thank you for following and supporting us in 2024. Maximon - The Longevity Company Builder's team wishes a healthy and prosperous New Year! Stay tuned for 2025! 🤩

Our venture Avea Life honored with the SEF.Growth High Potential Label We are happy and proud of our venture company Avea Life who has been awarded with the SEF.Growth High Potential Label. This is more than just a prize — it’s a testament to Avea’s unwavering commitment to improving health and longevity through scientifically backed solutions. This recognition by the Swiss Economic Forum highlights the venture’s visionary approach, strong leadership, and impactful contributions to the longevity space. Please find more details below on the comment 👇 how the founders of Avea, Pascal Rode, Sophie Chabloz,  Duri Granziol, and Teresa Budetta achieved break-even within only two years and how they expanded their product portfolio. Pascal also shares how the idea of this longevity supplement startup was born. Congratulations to the entire Avea team for this well-deserved recognition! Let’s continue to drive innovation and growth in the longevity sector together. 💪 #Longevity #Entrepreneurship

📢 Exciting News! We're thrilled to announce the publication of our latest paper (https://lnkd.in/dKphJdrp), which dives into the innovative field of longevity medicine and introduces the “Longevity Pyramid,” a framework designed to guide interventions that promote healthy aging. This comprehensive review highlights a tiered approach to longevity—starting from preventive strategies and diagnostics, progressing to lifestyle modifications, and culminating in personalized interventions tailored to individual genetic, lifestyle, and health profiles. This is the framework that we at Maximon use to evaluate and build new ventures in longevity, supporting our mission to advance healthy aging. A huge congratulations to the Maximon science team for this milestone achievement! This paper is the result of a collaborative effort involving many dedicated individuals from across the Maximon ecosystem. We’re immensely grateful to everyone who contributed their insights, expertise, and support to bring this important work to life. Here's to making strides in longevity science and supporting healthy aging for all! 🧬 #LongevityMedicine #HealthyAging #Maximon

Maximon is excited to be part of Startup Nights 2024! Join us today as our operating partner, Ildikó Sirman, together with Daniel Andres, Thomas Dübendorfer, Peter Kuhn, and Gian Reto à Porta share key strategies for securing favorable terms and fostering strong partnerships in shareholder agreements. This session promises actionable insights for founders and investors alike—don't miss out on practical advice to help you navigate critical negotiations. See you there! #startupnights2024

Maximon’s founding partner, Marc P. Bernegger, spoke at the 5th TimePie Longevity Forum (created by Fudan University alumni) in Shanghai, November 1-3, 2024. This landmark event brings together global leaders in aging science and longevity innovation to explore the latest breakthroughs shaping a healthier, longer future. Marc shared his insights about investing and building longevity companies, joining other experts dedicated to advancing healthy aging. Check out the article summarizing the event: https://lnkd.in/daSREVUW

Maximon is excited to announce that our founding partner, Marc P. Bernegger, will be participating in a panel discussion at the GCLS (Geneva College of Longevity Science) Semester Symposium on October 19th, 2024, alongside Thilo Kaltenbach (Roland Berger), Douglas Anderson (Club Vita LLP), and Alyaa Al Mulla (Longevity Public Policy Think Tank).  This panel, titled "Bridging Longevity: Enacting Policy and Engaging Markets," will dive into how policy and markets are key to advancing longevity science. Join us for this insightful discussion and be part of the conversation shaping the future of healthy aging. See you in Geneva! #LongevityScience

🚀 Introducing Longevity Investors NEWS – Your Gateway to the Future of Longevity and Investment! 🧬💡 Stay ahead in the rapidly evolving world of longevity science with our brand new weekly newsletter. Powered by AI, Longevity Investors NEWS brings you curated insights, strategic intelligence, and exclusive investment opportunities at the cutting edge of health and longevity. Gain exclusive insights, join a visionary community and stay ahead with groundbreaking advancements shaping the future. Subscribe now: 🔗 www.longevity-valley.ch #LongevityInvestors #LongevityInvestorsNews

Maximon partners are heading to Gstaad next week for the Longevity Investors Conference for an amazing few days of exploring the future of longevity and longevity investment. Don’t miss the chance to meet our partners and dive into the conversation. See you there! Event details: https://lnkd.in/dh_w_cwt Dr. Tobias Reichmuth Marc P. Bernegger Joerg Rieker Caroline Wagner Elisabeth Roider, MD, PhD, MBA #LongevityInvestors

Thank you to Longevity.Technology for covering the opening of the AYUN Longevity Clinic in Zurich. We’re excited to share this milestone in longevity and health innovation. Dr. med. Leonie Bode Vincent Aebi https://bit.ly/3XowG9j

The Frankfurter Allgemeine Zeitung explores how, among others, Maximon, Avea Life, and AYUN are pioneering the quest to outsmart aging in this latest feature. https://lnkd.in/d4YweixW